Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Gesundheit B et al. – ImmuKnow assay is a simple and fast immune–monitoring technique for patients undergoing alloHSCT, with potential to predict clinical course and facilitate prompt management of post–HSCT complications. The assay should be evaluated prospectively in clinical trials.


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address